Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

GLSI stock hub

Greenwich LifeSciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GLSIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

316.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GLSI

In the news

Latest news · GLSI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-543.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-341.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GLSI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001799788
Company name	Greenwich LifeSciences, Inc.
Country	United States
Country code	US
Cusip	396879108
Employees	8
Employees Change	1%
Employees Change Percent	14.29
Enterprise value	$312.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-09-25
Isin	US3968791083
Last refreshed	2026-05-10
Market cap	$316.7M
Market cap category	Small-Cap
Price	$22.86
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	GLSI
Website	https://greenwichlifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.15%
P/B ratio	144.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19.5M
Net Income Growth Years	0%
Profit Per Employee	$-2.4M
ROA	-254.2
Roa5y	-56.11
ROCE	-896.4
ROE	-543.4
Roe5y	-100.3
ROIC	-341.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	142.31%
Cagr3y	26.58%
Cagr5y	-7.52%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$3.8M
Cash	$3.8M
Current Assets	$3.8M
Current Liabilities	$1.6M
Equity	$2.2M
Liabilities	$1.6M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$3.8M
Net Cash By Market Cap	$1.2
Net Cash Growth	-34.61%
Net Debt Equity	$-1.74
Tangible Book Value	$2.2M
Tangible Book Value Per Share	$0.16
WACC	11.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.35
Net Working Capital	$-1.6M
Quick ratio	2.35
Working Capital	$2.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.05%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	142.16%
200-day SMA	17.33
3Y total return	102.84%
50-day SMA	24.9
50-day SMA vs 200-day SMA	50over200
5Y total return	-32.35%
All Time High	158.1
All Time High Change	-85.54%
All Time High Date	2020-12-09
All Time Low	3.26
All Time Low Change	600.8%
All Time Low Date	2020-11-04
ATR	1.84
Beta	1.38
Beta1y	1.86
Beta2y	1.56
Ch YTD	8.81
High	24.01
High52	34.1
High52 Date	2026-01-27
High52ch	-32.96%
Low	22.86
Low52	7.78
Low52 Date	2025-11-24
Low52ch	193.83%
Ma50ch	-8.18%
Premarket Change Percent	-2.16
Premarket Price	$23.11
Premarket Volume	552
Price vs 200-day SMA	31.95%
RSI	46.12
RSI Monthly	59.85
RSI Weekly	52.76
Sharpe ratio	1.38x
Sortino ratio	2.4
Total Return	-3.05%
Tr YTD	8.81
Tr1m	1.56%
Tr1w	-3.54%
Tr3m	-21.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.32
Operating Income	$-19.6M
Price target	$50
Price Target Change	$119

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,565,241%
Float Percent	47.39%
Shares Insiders	52.61%
Shares Institutions	9.72%
Shares Out	13,854,539
Shares Qo Q	2.02%
Shares Yo Y	3.05%
Short Float	23.19%
Short Ratio	9.12
Short Shares	10.99

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	122,265.2x
Bv Per Share	0.16
Ch1m	1.56
Ch1w	-3.54
Ch1y	142.2
Ch3m	-21.17
Ch3y	102.8
Ch5y	-32.35
Ch6m	164
Change	-3.22%
Change From Open	-1.21
Close	23.62
Days Gap	-2.03
Depreciation Amortization	2,682
Dollar Volume	1,735,531.2
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-19.6M
EBITDA	$-19.6M
EPS	$-1.46
F Score	1
Financing CF	6,575,613
Fiscal Year End	December
Founded	2,006
Ipr	297.6
Iprfo	297.6
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2025-11-14
Last Report Date	2025-09-30
Last Split Type	Never
Last10k Filing Date	2025-04-15
Ma150	19.29
Ma150ch	18.49%
Ma20	24.2
Ma20ch	-5.54%
Net CF	-2,015,389
Next Earnings Date	2026-05-22
Open	23.14
Optionable	No
Position In Range	0
Post Close	22.86
Postmarket Change Percent	0.39
Postmarket Price	$22.95
Pre Close	23.62
Price Date	2026-05-08
Ptbv Ratio	145
Relative Volume	0.62x
Share Based Comp	10,102,403
Tr6m	163.97%
Us State	Texas
Volume	75,920

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GLSI pay a dividend?

Capital-return profile for this ticker.

Performance

GLSI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GLSI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.7%

Float: +47.4% of shares outstanding

Insider ownership

+52.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GLSI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.1

Neutral momentum band

Price vs 200-day MA

+31.9%

50/200-day relationship not available

Beta (5Y)

1.38

More volatile than the market

Sharpe ratio

1.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GLSI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GLSI stock rating?

Greenwich LifeSciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GLSI analysis?

The full report lives at /stocks/GLSI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GLSI?

The latest report frames GLSI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GLSI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.